BridgeBio Pharma Inc (BBIO)
27.78
-1.49
(-5.09%)
USD |
NASDAQ |
May 23, 16:00
27.78
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Accounts Payable (Quarterly): 4.728M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.728M |
| December 31, 2023 | 10.66M |
| September 30, 2023 | 4.472M |
| June 30, 2023 | 3.874M |
| March 31, 2023 | 4.076M |
| December 31, 2022 | 11.56M |
| September 30, 2022 | 10.16M |
| June 30, 2022 | 8.793M |
| March 31, 2022 | 10.11M |
| December 31, 2021 | 11.88M |
| September 30, 2021 | 12.04M |
| Date | Value |
|---|---|
| June 30, 2021 | 22.33M |
| March 31, 2021 | 10.34M |
| December 31, 2020 | 8.945M |
| September 30, 2020 | 9.839M |
| June 30, 2020 | 12.84M |
| March 31, 2020 | 13.09M |
| December 31, 2019 | 8.852M |
| September 30, 2019 | 10.27M |
| June 30, 2019 | 16.06M |
| March 31, 2019 | 12.34M |
| December 31, 2018 | 13.51M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.874M
Minimum
Jun 2023
22.33M
Maximum
Jun 2021
10.25M
Average
10.21M
Median
Accounts Payable (Quarterly) Benchmarks
| Pfizer Inc | 5.591B |
| Alnylam Pharmaceuticals Inc | 78.15M |
| Regenxbio Inc | 31.36M |
| ACADIA Pharmaceuticals Inc | 19.33M |
| Biomarin Pharmaceutical Inc | 292.24M |